sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Human Microbiome Market Size, Status and Forecast 2020-2026

Global Human Microbiome Market Size, Status and Forecast 2020-2026

Category : Pharmaceuticals and Healthcare QY Research Pages :127
Published Date : 2020-06-25

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Human Microbiome Market with our analysts monitoring the situation across the globe.
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult). These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes. An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease. At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Microbiome market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Human Microbiome industry. Based on our recent survey, we have several different scenarios about the Human Microbiome YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 276.5 million in 2019. The market size of Human Microbiome will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome market in terms of revenue. Players, stakeholders, and other participants in the global Human Microbiome market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026. Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Human Microbiome market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Human Microbiome market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome market. The following players are covered in this report: Vedanta Seres Therapeutics Second Genome Rebiotix ActoGeniX Enterome BioScience AvidBiotics 4D Pharma Research Ltd Enterologics Metabogen Metabiomics Ritter Pharmaceuticals Osel Symberix Miomics Symbiotix Biotherapies MicroBiome Therapeutics LLC Human Microbiome Breakdown Data by Type Gastrointestinal Tract Human Micobiome Urogenital Tract Human Micobiome Other Human Microbiome Breakdown Data by Application Treatment Diagnosis
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Human Microbiome Revenue 1.4 Market Analysis by Type 1.4.1 Global Human Microbiome Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Gastrointestinal Tract Human Micobiome 1.4.3 Urogenital Tract Human Micobiome 1.4.4 Other 1.5 Market by Application 1.5.1 Global Human Microbiome Market Share by Application: 2020 VS 2026 1.5.2 Treatment 1.5.3 Diagnosis 1.6 Coronavirus Disease 2019 (Covid-19): Human Microbiome Industry Impact 1.6.1 How the Covid-19 is Affecting the Human Microbiome Industry 1.6.1.1 Human Microbiome Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Human Microbiome Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Human Microbiome Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Human Microbiome Market Perspective (2015-2026) 2.2 Human Microbiome Growth Trends by Regions 2.2.1 Human Microbiome Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Human Microbiome Historic Market Share by Regions (2015-2020) 2.2.3 Human Microbiome Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Human Microbiome Market Growth Strategy 2.3.6 Primary Interviews with Key Human Microbiome Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Human Microbiome Players by Market Size 3.1.1 Global Top Human Microbiome Players by Revenue (2015-2020) 3.1.2 Global Human Microbiome Revenue Market Share by Players (2015-2020) 3.1.3 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Human Microbiome Market Concentration Ratio 3.2.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2019 3.3 Human Microbiome Key Players Head office and Area Served 3.4 Key Players Human Microbiome Product Solution and Service 3.5 Date of Enter into Human Microbiome Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Human Microbiome Historic Market Size by Type (2015-2020) 4.2 Global Human Microbiome Forecasted Market Size by Type (2021-2026) 5 Human Microbiome Breakdown Data by Application (2015-2026) 5.1 Global Human Microbiome Market Size by Application (2015-2020) 5.2 Global Human Microbiome Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Human Microbiome Market Size (2015-2020) 6.2 Human Microbiome Key Players in North America (2019-2020) 6.3 North America Human Microbiome Market Size by Type (2015-2020) 6.4 North America Human Microbiome Market Size by Application (2015-2020) 7 Europe 7.1 Europe Human Microbiome Market Size (2015-2020) 7.2 Human Microbiome Key Players in Europe (2019-2020) 7.3 Europe Human Microbiome Market Size by Type (2015-2020) 7.4 Europe Human Microbiome Market Size by Application (2015-2020) 8 China 8.1 China Human Microbiome Market Size (2015-2020) 8.2 Human Microbiome Key Players in China (2019-2020) 8.3 China Human Microbiome Market Size by Type (2015-2020) 8.4 China Human Microbiome Market Size by Application (2015-2020) 9 Japan 9.1 Japan Human Microbiome Market Size (2015-2020) 9.2 Human Microbiome Key Players in Japan (2019-2020) 9.3 Japan Human Microbiome Market Size by Type (2015-2020) 9.4 Japan Human Microbiome Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Human Microbiome Market Size (2015-2020) 10.2 Human Microbiome Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Human Microbiome Market Size by Type (2015-2020) 10.4 Southeast Asia Human Microbiome Market Size by Application (2015-2020) 11 India 11.1 India Human Microbiome Market Size (2015-2020) 11.2 Human Microbiome Key Players in India (2019-2020) 11.3 India Human Microbiome Market Size by Type (2015-2020) 11.4 India Human Microbiome Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Human Microbiome Market Size (2015-2020) 12.2 Human Microbiome Key Players in Central & South America (2019-2020) 12.3 Central & South America Human Microbiome Market Size by Type (2015-2020) 12.4 Central & South America Human Microbiome Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Vedanta 13.1.1 Vedanta Company Details 13.1.2 Vedanta Business Overview and Its Total Revenue 13.1.3 Vedanta Human Microbiome Introduction 13.1.4 Vedanta Revenue in Human Microbiome Business (2015-2020)) 13.1.5 Vedanta Recent Development 13.2 Seres Therapeutics 13.2.1 Seres Therapeutics Company Details 13.2.2 Seres Therapeutics Business Overview and Its Total Revenue 13.2.3 Seres Therapeutics Human Microbiome Introduction 13.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2015-2020) 13.2.5 Seres Therapeutics Recent Development 13.3 Second Genome 13.3.1 Second Genome Company Details 13.3.2 Second Genome Business Overview and Its Total Revenue 13.3.3 Second Genome Human Microbiome Introduction 13.3.4 Second Genome Revenue in Human Microbiome Business (2015-2020) 13.3.5 Second Genome Recent Development 13.4 Rebiotix 13.4.1 Rebiotix Company Details 13.4.2 Rebiotix Business Overview and Its Total Revenue 13.4.3 Rebiotix Human Microbiome Introduction 13.4.4 Rebiotix Revenue in Human Microbiome Business (2015-2020) 13.4.5 Rebiotix Recent Development 13.5 ActoGeniX 13.5.1 ActoGeniX Company Details 13.5.2 ActoGeniX Business Overview and Its Total Revenue 13.5.3 ActoGeniX Human Microbiome Introduction 13.5.4 ActoGeniX Revenue in Human Microbiome Business (2015-2020) 13.5.5 ActoGeniX Recent Development 13.6 Enterome BioScience 13.6.1 Enterome BioScience Company Details 13.6.2 Enterome BioScience Business Overview and Its Total Revenue 13.6.3 Enterome BioScience Human Microbiome Introduction 13.6.4 Enterome BioScience Revenue in Human Microbiome Business (2015-2020) 13.6.5 Enterome BioScience Recent Development 13.7 AvidBiotics 13.7.1 AvidBiotics Company Details 13.7.2 AvidBiotics Business Overview and Its Total Revenue 13.7.3 AvidBiotics Human Microbiome Introduction 13.7.4 AvidBiotics Revenue in Human Microbiome Business (2015-2020) 13.7.5 AvidBiotics Recent Development 13.8 4D Pharma Research Ltd 13.8.1 4D Pharma Research Ltd Company Details 13.8.2 4D Pharma Research Ltd Business Overview and Its Total Revenue 13.8.3 4D Pharma Research Ltd Human Microbiome Introduction 13.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2015-2020) 13.8.5 4D Pharma Research Ltd Recent Development 13.9 Enterologics 13.9.1 Enterologics Company Details 13.9.2 Enterologics Business Overview and Its Total Revenue 13.9.3 Enterologics Human Microbiome Introduction 13.9.4 Enterologics Revenue in Human Microbiome Business (2015-2020) 13.9.5 Enterologics Recent Development 13.10 Metabogen 13.10.1 Metabogen Company Details 13.10.2 Metabogen Business Overview and Its Total Revenue 13.10.3 Metabogen Human Microbiome Introduction 13.10.4 Metabogen Revenue in Human Microbiome Business (2015-2020) 13.10.5 Metabogen Recent Development 13.11 Metabiomics 10.11.1 Metabiomics Company Details 10.11.2 Metabiomics Business Overview and Its Total Revenue 10.11.3 Metabiomics Human Microbiome Introduction 10.11.4 Metabiomics Revenue in Human Microbiome Business (2015-2020) 10.11.5 Metabiomics Recent Development 13.12 Ritter Pharmaceuticals 10.12.1 Ritter Pharmaceuticals Company Details 10.12.2 Ritter Pharmaceuticals Business Overview and Its Total Revenue 10.12.3 Ritter Pharmaceuticals Human Microbiome Introduction 10.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2015-2020) 10.12.5 Ritter Pharmaceuticals Recent Development 13.13 Osel 10.13.1 Osel Company Details 10.13.2 Osel Business Overview and Its Total Revenue 10.13.3 Osel Human Microbiome Introduction 10.13.4 Osel Revenue in Human Microbiome Business (2015-2020) 10.13.5 Osel Recent Development 13.14 Symberix 10.14.1 Symberix Company Details 10.14.2 Symberix Business Overview and Its Total Revenue 10.14.3 Symberix Human Microbiome Introduction 10.14.4 Symberix Revenue in Human Microbiome Business (2015-2020) 10.14.5 Symberix Recent Development 13.15 Miomics 10.15.1 Miomics Company Details 10.15.2 Miomics Business Overview and Its Total Revenue 10.15.3 Miomics Human Microbiome Introduction 10.15.4 Miomics Revenue in Human Microbiome Business (2015-2020) 10.15.5 Miomics Recent Development 13.16 Symbiotix Biotherapies 10.16.1 Symbiotix Biotherapies Company Details 10.16.2 Symbiotix Biotherapies Business Overview and Its Total Revenue 10.16.3 Symbiotix Biotherapies Human Microbiome Introduction 10.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2015-2020) 10.16.5 Symbiotix Biotherapies Recent Development 13.17 MicroBiome Therapeutics LLC 10.17.1 MicroBiome Therapeutics LLC Company Details 10.17.2 MicroBiome Therapeutics LLC Business Overview and Its Total Revenue 10.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction 10.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2015-2020) 10.17.5 MicroBiome Therapeutics LLC Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. Human Microbiome Key Market Segments Table 2. Key Players Covered: Ranking by Human Microbiome Revenue Table 3. Ranking of Global Top Human Microbiome Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Gastrointestinal Tract Human Micobiome Table 6. Key Players of Urogenital Tract Human Micobiome Table 7. Key Players of Other Table 8. COVID-19 Impact Global Market: (Four Human Microbiome Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Human Microbiome Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Human Microbiome Players to Combat Covid-19 Impact Table 13. Global Human Microbiome Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Human Microbiome Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Human Microbiome Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Human Microbiome Market Share by Regions (2015-2020) Table 17. Global Human Microbiome Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Human Microbiome Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. Human Microbiome Market Growth Strategy Table 23. Main Points Interviewed from Key Human Microbiome Players Table 24. Global Human Microbiome Revenue by Players (2015-2020) (Million US$) Table 25. Global Human Microbiome Market Share by Players (2015-2020) Table 26. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2019) Table 27. Global Human Microbiome by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players Human Microbiome Product Solution and Service Table 30. Date of Enter into Human Microbiome Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 33. Global Human Microbiome Market Size Share by Type (2015-2020) Table 34. Global Human Microbiome Revenue Market Share by Type (2021-2026) Table 35. Global Human Microbiome Market Size Share by Application (2015-2020) Table 36. Global Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 37. Global Human Microbiome Market Size Share by Application (2021-2026) Table 38. North America Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 39. North America Key Players Human Microbiome Market Share (2019-2020) Table 40. North America Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 41. North America Human Microbiome Market Share by Type (2015-2020) Table 42. North America Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 43. North America Human Microbiome Market Share by Application (2015-2020) Table 44. Europe Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 45. Europe Key Players Human Microbiome Market Share (2019-2020) Table 46. Europe Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 47. Europe Human Microbiome Market Share by Type (2015-2020) Table 48. Europe Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 49. Europe Human Microbiome Market Share by Application (2015-2020) Table 50. China Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 51. China Key Players Human Microbiome Market Share (2019-2020) Table 52. China Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 53. China Human Microbiome Market Share by Type (2015-2020) Table 54. China Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 55. China Human Microbiome Market Share by Application (2015-2020) Table 56. Japan Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 57. Japan Key Players Human Microbiome Market Share (2019-2020) Table 58. Japan Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 59. Japan Human Microbiome Market Share by Type (2015-2020) Table 60. Japan Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 61. Japan Human Microbiome Market Share by Application (2015-2020) Table 62. Southeast Asia Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 63. Southeast Asia Key Players Human Microbiome Market Share (2019-2020) Table 64. Southeast Asia Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 65. Southeast Asia Human Microbiome Market Share by Type (2015-2020) Table 66. Southeast Asia Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 67. Southeast Asia Human Microbiome Market Share by Application (2015-2020) Table 68. India Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 69. India Key Players Human Microbiome Market Share (2019-2020) Table 70. India Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 71. India Human Microbiome Market Share by Type (2015-2020) Table 72. India Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 73. India Human Microbiome Market Share by Application (2015-2020) Table 74. Central & South America Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 75. Central & South America Key Players Human Microbiome Market Share (2019-2020) Table 76. Central & South America Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 77. Central & South America Human Microbiome Market Share by Type (2015-2020) Table 78. Central & South America Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 79. Central & South America Human Microbiome Market Share by Application (2015-2020) Table 80. Vedanta Company Details Table 81. Vedanta Business Overview Table 82. Vedanta Product Table 83. Vedanta Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 84. Vedanta Recent Development Table 85. Seres Therapeutics Company Details Table 86. Seres Therapeutics Business Overview Table 87. Seres Therapeutics Product Table 88. Seres Therapeutics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 89. Seres Therapeutics Recent Development Table 90. Second Genome Company Details Table 91. Second Genome Business Overview Table 92. Second Genome Product Table 93. Second Genome Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 94. Second Genome Recent Development Table 95. Rebiotix Company Details Table 96. Rebiotix Business Overview Table 97. Rebiotix Product Table 98. Rebiotix Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 99. Rebiotix Recent Development Table 100. ActoGeniX Company Details Table 101. ActoGeniX Business Overview Table 102. ActoGeniX Product Table 103. ActoGeniX Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 104. ActoGeniX Recent Development Table 105. Enterome BioScience Company Details Table 106. Enterome BioScience Business Overview Table 107. Enterome BioScience Product Table 108. Enterome BioScience Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 109. Enterome BioScience Recent Development Table 110. AvidBiotics Company Details Table 111. AvidBiotics Business Overview Table 112. AvidBiotics Product Table 113. AvidBiotics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 114. AvidBiotics Recent Development Table 115. 4D Pharma Research Ltd Business Overview Table 116. 4D Pharma Research Ltd Product Table 117. 4D Pharma Research Ltd Company Details Table 118. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 119. 4D Pharma Research Ltd Recent Development Table 120. Enterologics Company Details Table 121. Enterologics Business Overview Table 122. Enterologics Product Table 123. Enterologics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 124. Enterologics Recent Development Table 125. Metabogen Company Details Table 126. Metabogen Business Overview Table 127. Metabogen Product Table 128. Metabogen Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 129. Metabogen Recent Development Table 130. Metabiomics Company Details Table 131. Metabiomics Business Overview Table 132. Metabiomics Product Table 133. Metabiomics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 134. Metabiomics Recent Development Table 135. Ritter Pharmaceuticals Company Details Table 136. Ritter Pharmaceuticals Business Overview Table 137. Ritter Pharmaceuticals Product Table 138. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 139. Ritter Pharmaceuticals Recent Development Table 140. Osel Company Details Table 141. Osel Business Overview Table 142. Osel Product Table 143. Osel Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 144. Osel Recent Development Table 145. Symberix Company Details Table 146. Symberix Business Overview Table 147. Symberix Product Table 148. Symberix Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 149. Symberix Recent Development Table 150. Miomics Company Details Table 151. Miomics Business Overview Table 152. Miomics Product Table 153. Miomics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 154. Miomics Recent Development Table 155. Symbiotix Biotherapies Company Details Table 156. Symbiotix Biotherapies Business Overview Table 157. Symbiotix Biotherapies Product Table 158. Symbiotix Biotherapies Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 159. Symbiotix Biotherapies Recent Development Table 160. MicroBiome Therapeutics LLC Company Details Table 161. MicroBiome Therapeutics LLC Business Overview Table 162. MicroBiome Therapeutics LLC Product Table 163. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 164. MicroBiome Therapeutics LLC Recent Development Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Microbiome Market Share by Type: 2020 VS 2026 Figure 2. Gastrointestinal Tract Human Micobiome Features Figure 3. Urogenital Tract Human Micobiome Features Figure 4. Other Features Figure 5. Global Human Microbiome Market Share by Application: 2020 VS 2026 Figure 6. Treatment Case Studies Figure 7. Diagnosis Case Studies Figure 8. Human Microbiome Report Years Considered Figure 9. Global Human Microbiome Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Human Microbiome Market Share by Regions: 2020 VS 2026 Figure 11. Global Human Microbiome Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Human Microbiome Market Share by Players in 2019 Figure 14. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2019 Figure 16. North America Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Vedanta Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Vedanta Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 25. Seres Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 27. Second Genome Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Second Genome Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 29. Rebiotix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Rebiotix Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 31. ActoGeniX Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 33. Enterome BioScience Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 35. AvidBiotics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 37. 4D Pharma Research Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 39. Enterologics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Enterologics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 41. Metabogen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Metabogen Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 43. Metabiomics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Metabiomics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 45. Ritter Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 47. Osel Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Osel Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 49. Symberix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Symberix Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 51. Miomics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Miomics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 53. Symbiotix Biotherapies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 55. MicroBiome Therapeutics LLC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Get Free Sample

Related Reports

Global Human Microbiome Market Size, Status and Forecast 2020-2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Human Microbiome Market Size, Status and Forecast 2020-2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Human Microbiome Market Size, Status and Forecast 2020-2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Human Microbiome Market Size, Status and Forecast 2020-2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Human Microbiome Market Size, Status and Forecast 2020-2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)